Skip to main content
UCB's Global Corporate Website
instagram
facebook
twitter
youtube
linkedin
rss
Listen
30 Apr 2015
UCB Interim Report for the first three months of 2015:
Read More
29 Apr 2015
Acquisition of own shares (April 29)
Read More
20 Apr 2015
Important UCB presence at the 2015 American Academy of Neurology Meeting
Read More
8 Apr 2015
Acquisition of Own Shares
Read More
1 Apr 2015
UCB to focus on core business in India
Read More
27 Mar 2015
UCB completes institutional Eurobond offering
Read More
27 Feb 2015
UCB Full Year Report 2014:
Read More
18 Feb 2015
UCB leads epilepsy hackathon to support patient needs through digital tools and services
Read More
5 Feb 2015
UCB advances Neupro® (rotigotine transdermal patch) in China: positive Phase 3 program in patients with Parkinson’s disease
Read More
21 Jan 2015
UCB announces US and EU regulatory filings for the investigational antiepileptic drug brivaracetam
Read More
Pagination
First page
Previous page
‹ Previous
…
Page
43
Page
44
Page
45
Page
46
Current page
47
Page
48
Page
49
Page
50
Page
51
…
Next page
Next ›
Last page
Subscribe to
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zealand – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – español y portugués
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Deutsch
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
×
instagram
facebook
twitter
youtube
linkedin
rss